I agree B2R wholeheartedly!!
Why would you partner when you can compete with superior innovation to ‘no mess’ applicators. I think many are still stuck on the idea our success can only be achieved by partnering with these big guys. Things have changed. Move on, it’s about JV’s and maximum revenues/profits.
- Forums
- ASX - By Stock
- WFL
- GSK Voltaren
GSK Voltaren, page-3
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable